164 related articles for article (PubMed ID: 29985577)
1. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
[TBL] [Abstract][Full Text] [Related]
2. Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.
Li Z; Chen G; Ding L; Wang Y; Zhu C; Wang K; Li J; Sun M; Oupicky D
Mol Ther; 2019 Dec; 27(12):2100-2110. PubMed ID: 31481310
[TBL] [Abstract][Full Text] [Related]
3. Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous siRNA Delivery.
Chen G; Wang K; Wang Y; Wu P; Sun M; Oupický D
Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29280311
[TBL] [Abstract][Full Text] [Related]
4. Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.
Chen Y; Li J; Oupický D
Bioconjug Chem; 2018 Feb; 29(2):296-305. PubMed ID: 29338191
[TBL] [Abstract][Full Text] [Related]
5. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
[TBL] [Abstract][Full Text] [Related]
7. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis.
Wang Y; Kumar S; Rachagani S; Sajja BR; Xie Y; Hang Y; Jain M; Li J; Boska MD; Batra SK; Oupický D
Biomaterials; 2016 Sep; 101():108-120. PubMed ID: 27267632
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.
Wang Y; Ding L; Li Z; Chen G; Sun M; Oupicky D
J Control Release; 2019 Nov; 314():12-24. PubMed ID: 31644934
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists.
Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D
Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651
[TBL] [Abstract][Full Text] [Related]
10. Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer.
Zhou Y; Yu F; Zhang F; Chen G; Wang K; Sun M; Li J; Oupický D
Biomacromolecules; 2018 Feb; 19(2):392-401. PubMed ID: 29350899
[TBL] [Abstract][Full Text] [Related]
11. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
[TBL] [Abstract][Full Text] [Related]
12. Combining Fluorination and Bioreducibility for Improved siRNA Polyplex Delivery.
Chen G; Wang K; Hu Q; Ding L; Yu F; Zhou Z; Zhou Y; Li J; Sun M; Oupický D
ACS Appl Mater Interfaces; 2017 Feb; 9(5):4457-4466. PubMed ID: 28135066
[TBL] [Abstract][Full Text] [Related]
13. Chitosan nanoparticle-delivered siRNA reduces
Yu S; Chen Y; Li X; Gao Z; Liu G
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28446538
[TBL] [Abstract][Full Text] [Related]
14. Development of functional poly(amido amine) CXCR4 antagonists with the ability to mobilize leukocytes and deliver nucleic acids.
Wang Y; Hazeldine ST; Li J; Oupický D
Adv Healthc Mater; 2015 Apr; 4(5):729-38. PubMed ID: 25491178
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
16. Plasmid-based STAT3-siRNA efficiently inhibits breast tumor growth and metastasis in mice.
Dai L; Cheng L; Zhang X; Jiang Q; Zhang S; Wang S; Li Y; Chen X; DU T; Yang Y; Tian H; Fan P; Yan N; Dai L; Wei Y; Deng H
Neoplasma; 2011; 58(6):538-47. PubMed ID: 21895408
[TBL] [Abstract][Full Text] [Related]
17. Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice.
Bastaki S; Aravindhan S; Ahmadpour Saheb N; Afsari Kashani M; Evgenievich Dorofeev A; Karoon Kiani F; Jahandideh H; Beigi Dargani F; Aksoun M; Nikkhoo A; Masjedi A; Mahmoodpoor A; Ahmadi M; Dolati S; Namvar Aghdash S; Jadidi-Niaragh F
Life Sci; 2021 Feb; 266():118847. PubMed ID: 33309720
[TBL] [Abstract][Full Text] [Related]
18. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
19. Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
Taniguchi H; Natori Y; Miyagi Y; Hayashi K; Nagamura F; Kataoka K; Imai K
Int J Cancer; 2021 Aug; 149(3):646-656. PubMed ID: 33783816
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]